Approvals/TGA/SITAGLIPTIN/METFORMIN MAPLE 50/850 sitagliptin (as hydrochloride monohydrate) 50 mg and metformin hydrochloride 850 mg tablet blister pack

Approved

STANDARD

SITAGLIPTIN/METFORMIN MAPLE 50/850 sitagliptin (as hydrochloride monohydrate) 50 mg and metformin hydrochloride 850 mg tablet blister pack

Maple Healthcare Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: May 29, 2025
Approval ID: ee0f25e22199b0ed
Company: Maple Healthcare Pty Ltd
Type: Standard

Approval Details

Approval Id: ee0f25e22199b0ed
Product Name: SITAGLIPTIN/METFORMIN MAPLE 50/850 sitagliptin (as hydrochloride monohydrate) 50 mg and metformin hydrochloride 850 mg tablet blister pack
Artg Id: 386884
Artg Name: SITAGLIPTIN/METFORMIN MAPLE 50/850 sitagliptin (as hydrochloride monohydrate) 50 mg and metformin hydrochloride 850 mg tablet blister pack
Sponsor: Maple Healthcare Pty Ltd
Company Detail Path: /organization/maple-healthcare-pty-ltd
Artg Date: 2023-04-06
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Active Ingredients

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

ee0f25e22199b0ed

Type

Standard

Back to TGA Approvals